Advertisement

Topics

Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial

20:00 EDT 13 May 2019 | BioSpace

The trial showed that the company's auto-injector administered treatment delivered the same results as a previous trial using a pre-filled syringe.

Original Article: Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial

NEXT ARTICLE

More From BioPortfolio on "Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial"

Advertisement
Quick Search
Advertisement
Advertisement